NIKE Bets on EMEA Growth: Can This Strategy Pay Off in FY26? — Positive

NKE   Zacks Investment Research — August 13, 2025

NKE's EMEA strategy drives growth by building on marketplace streamlining and boosting NIKE Digital through an integrated channel approach.

image for news NIKE Bets on EMEA Growth: Can This Strategy Pay Off in FY26?

Novo Nordisk Rises 6% So Far in August: How to Play the Stock — Neutral

NVO   Zacks Investment Research — August 13, 2025

NVO stock climbs nearly 6% in August as Lilly's oral obesity candidate setback pivots investor sentiment toward the former's advancing pipeline.

image for news Novo Nordisk Rises 6% So Far in August: How to Play the Stock

Turkcell Iletişim Hizmetleri: Second Quarter 2025 Results — Neutral

TKC   Business Wire — August 13, 2025

ISTANBUL--(BUSINESS WIRE)--Turkcell Iletişim Hizmetleri (NYSE:TKC) (BIST:TCELL): Please note that all financial data is consolidated and comprises that of Turkcell Iletisim Hizmetleri A.S. (the “Company” or “Turkcell”) and its subsidiaries and associates (together referred to as the “Group”) unless otherwise stated. Our revenue segmentation was revised as of Q1 2025. Within this scope, all past data have been restated for comparability purposes. For a comprehensive explanation, please refer to.

image for news Turkcell Iletişim Hizmetleri: Second Quarter 2025 Results

MINNEAPOLIS, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Sun Country Airlines (NASDAQ: SNCY) announced today that D. Torque Zubeck, formerly a managing director with Alaska Airlines, will join Sun Country as Senior Vice President and Chief Financial Officer on Tuesday, September 2.

image for news Sun Country Airlines names D. Torque Zubeck as Senior Vice President and Chief Financial Officer

EWM: Road To Recovery — Positive

EWM   Seeking Alpha — August 13, 2025

EWM which focuses on 30 stocks from Malaysia is up by only low single-digits this year, and underperforming emerging markets and global markets quite significantly. We now feel EWM could witness better prospects ahead. Malaysia's macro outlook is stabilizing, with improved GDP growth, supportive government policies, and central bank rate cuts boosting domestic demand.

image for news EWM: Road To Recovery

BiomX Inc. (PHGE) Q2 2025 Earnings Call Transcript — Neutral

PHGE   Seeking Alpha — August 13, 2025

BiomX Inc. (NYSE:PHGE ) Q2 2025 Earnings Conference Call August 13, 2025 8:00 AM ET Company Participants Jonathan Eitan Solomon - CEO & Director Marina Wolfson - CFO & Secretary Conference Call Participants I-Eh Jen - Laidlaw & Company (UK) Ltd., Research Division Joseph Pantginis - H.C.

image for news BiomX Inc. (PHGE) Q2 2025 Earnings Call Transcript

NASHVILLE, Tenn.--(BUSINESS WIRE)--With the indulgence of beach barbeques and happy hours fading into rear view mirrors, consumers will stock up on health and wellness related foods and beverages, while shopping for the Fall. AN Supps, a division of Applied Nutrition PLC, has responded to this trend - joining forces with Chiquita® Brands International and thousands of Walmart U.S. stores to deliver protein and pre-workout sports beverage mixes. AN Supps began its partnership with Chiquita® earl.

image for news AN Supps Expands Innovation With Iconic Chiquita® Brand Collab and a Nationwide Walmart U.S. Launch

SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- On August 5, 2025, investors in Hims & Hers Health (NYSE: HIMS) declined almost 11% in another sell-off after the company disclosed that it would lower revenue recognized per customer specific to its so-called personalized GLP-1 component, a medication the company compounds to treat weight loss. This disclosure comes as the company previously experienced a sell-off in its shares which triggered a securities class action lawsuit tied to a cancelled collaboration with pharmaceutical giant Novo Nordisk to expand the availability of one of two FDA-approved weight loss drugs -- Wegovy® -- to …

image for news HIMS 2-WEEK DEADLINE ALERT: HIMS Shares Decline Amid Lower Revenue Per Order For GLP-1 Following Novo Nordisk Collaboration Termination, Securities Class Action Pending -- Hagens Berman

MKL Outperforms Industry, Trades at a Discount: How to Play the Stock — Positive

MKL   Zacks Investment Research — August 13, 2025

Markel Group is set to grow on rate increases, strategic buyouts, new business volume, solid capital position and prudent capital deployment.

image for news MKL Outperforms Industry, Trades at a Discount: How to Play the Stock

Expectations for September Rate Cut Soar — Positive

EAT   Zacks Investment Research — August 13, 2025

Expectations for September Rate Cut Soar.

image for news Expectations for September Rate Cut Soar

Large-Cap ETF (SPLG) Hits New 52-Week High — Positive

SPLG   Zacks Investment Research — August 13, 2025

SPLG surges to a 52-week high, lifted by record S&P 500 levels, rate-cut optimism, and AI-driven market momentum.

image for news Large-Cap ETF (SPLG) Hits New 52-Week High

Crown Castle Stock Gains 16.3% in 6 Months: Will the Trend Continue? — Positive

CCI   Zacks Investment Research — August 13, 2025

CCI's 16.3% six-month climb is driven by 5G growth, tower expansion and stable revenues from long-term leases.

image for news Crown Castle Stock Gains 16.3% in 6 Months: Will the Trend Continue?

CRM Bets on ADAM Framework: Will it Fortify Leadership in Agentic AI? — Positive

CRM   Zacks Investment Research — August 13, 2025

Salesforce's ADAM framework, which includes Agents, Data, Apps, and Metadata, aims to power safe, scalable AI agents and fuel the company's next growth phase.

image for news CRM Bets on ADAM Framework: Will it Fortify Leadership in Agentic AI?

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO

ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:00 AM Eastern Time on Friday, August 15th, 2025, to discuss the company's financial results for the second quarter ended June 30, 2025, as well as the company's corporate progress and other developments.

image for news Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call

CoreWeave Tanks 15% Despite AI Growth Surge. Time to Back Up the Truck? — Neutral

CRWV   24/7 Wall Street — August 13, 2025

Key Points in This Article: CoreWeave's (CRWV) Q2 revenue of $1.21 billion surpassed estimates, driven by AI demand.

image for news CoreWeave Tanks 15% Despite AI Growth Surge. Time to Back Up the Truck?

AST SpaceMobile: Intermittent Service Isn't Enough — Negative

ASTS   Seeking Alpha — August 13, 2025

AST SpaceMobile continues to miss satellite launch targets, delaying commercial service and raising doubts about execution. Competitive threats from Starlink and T-Mobile have intensified, making ASTS's late entry and value proposition less compelling. Revenue projections appear overly optimistic given persistent delays, questionable demand, and reliance on MNO partnerships for growth.

image for news AST SpaceMobile: Intermittent Service Isn't Enough

Mersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call Transcript — Neutral

MRSN   Seeking Alpha — August 13, 2025

Mersana Therapeutics, Inc. (NASDAQ:MRSN ) Q2 2025 Earnings Conference Call August 13, 2025 8:00 AM ET Company Participants Brian C. DeSchuytner - Senior VP, CFO & COO Jason Fredette - Senior Vice President of Investor Relations & Corporate Communications Martin H.

image for news Mersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call Transcript

Hudbay Minerals surges on $600M Mitsubishi investment in Copper World project — Positive

CPER  HBM  JJC   Proactive Investors — August 13, 2025

HudBay Minerals Inc. (TSX:HBM) shares surged after the miner announced a $600 million strategic investment from Mitsubishi for a 30% joint venture interest in the Copper World project in Arizona. Announced alongside its Q2 earnings, the deal includes an initial cash investment of $420 million, with $180 million to follow within 18 months.

image for news Hudbay Minerals surges on $600M Mitsubishi investment in Copper World project

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE